NASDAQ : PDSB
PDS Biotechnology Corporation — Financial statements
Healthcare · Biotechnology · United States
Last price 1.55 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 112.34M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 12.13M | 12.52M | 13.76M | 15.28M | 12.24M | 10.18M |
| Research & Development | 15.70M | 19.03M | 22.57M | 27.76M | 29.43M | 11.25M |
| Operating Expenses | 27.83M | 31.54M | 36.32M | 43.05M | 41.67M | 21.44M |
| Operating Income | -27.83M | -31.54M | -36.32M | -43.05M | -41.67M | -21.44M |
| Interest Expense | -6.66M | -5.34M | -4.67M | -4.21M | -1.32M | |
| Interest & Investment Income | 817.99K | 1.22M | 2.51M | 2.90M | 935.18K | 4.35K |
| EBT Excluding Unusual Items | -33.67M | -35.67M | -38.48M | -44.35M | -42.05M | -21.43M |
| Pretax Income | -33.67M | -35.67M | -38.48M | -44.35M | -42.05M | -21.43M |
| Income Tax Expense | -1.17M | -869.17K | -1.41M | -1.20M | -4.52M | |
| Net Income | -33.67M | -34.50M | -37.61M | -42.94M | -40.85M | -16.92M |
| Net Income to Common | -33.67M | -34.50M | -37.61M | -42.94M | -40.85M | -16.92M |
| Shares Outstanding (Basic) | 52.60M | 46.38M | 36.45M | 30.95M | 28.60M | 25.60M |
| Shares Outstanding (Diluted) | 52.60M | 46.38M | 36.45M | 30.95M | 28.60M | 25.60M |
| EPS (Basic) | -0.64 | -0.74 | -1.03 | -1.39 | -1.43 | -0.66 |
| EPS (Diluted) | -0.64 | -0.74 | -1.03 | -1.39 | -1.43 | -0.66 |
| Free Cash Flow | -16.78M | -27.75M | -35.06M | -33.64M | -25.71M | -12.49M |
| Free Cash Flow Per Share | -0.32 | -0.60 | -0.96 | -1.09 | -0.90 | -0.49 |
| EBITDA | -27.77M | -31.48M | -36.26M | -42.99M | -41.62M | -21.43M |
| D&A For EBITDA | 60.52K | 60.52K | 59.79K | 57.33K | 49.08K | 5.36K |
| EBIT | -27.83M | -31.54M | -36.32M | -43.05M | -41.67M | -21.44M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 5.60M | 26.71M | 41.69M | 56.56M | 73.82M | 65.24M |
| Cash & Short-Term Investments | 5.60M | 26.71M | 41.69M | 56.56M | 73.82M | 65.24M |
| Prepaid Expenses | 1.45M | 1.54M | 3.36M | 2.49M | 2.66M | 1.60M |
| Total Current Assets | 7.05M | 28.25M | 45.05M | 59.06M | 76.48M | 66.84M |
| Property, Plant & Equipment | 213.44K | 243.70K | 304.21K | 335.00K | 527.53K | 357.70K |
| Other Long-Term Assets | 1.55M | 2.00M | ||||
| Total Assets | 8.81M | 30.49M | 45.36M | 59.39M | 77.01M | 67.20M |
| Accounts Payable | 6.39M | 3.57M | 1.68M | 6.98M | 1.22M | 1.31M |
| Accrued Expenses | 1.63M | 742.23K | 2.84M | 2.42M | 8.31M | 2.19M |
| Short-Term Debt | 5.13M | 12.50M | 4.17M | |||
| Current Portion of Leases | 31.70K | 36.17K | 61.12K | 55.79K | 288.04K | 258.92K |
| Total Current Liabilities | 12.38M | 9.48M | 17.09M | 13.63M | 9.82M | 3.76M |
| Long-Term Debt | 11.73M | 9.20M | 19.51M | 23.02M | ||
| Long-Term Leases | 9.48K | 25.69K | 61.85K | 122.97K | 164.01K | 231.43K |
| Total Liabilities | 12.39M | 21.24M | 26.35M | 33.26M | 33.01M | 3.99M |
| Common Stock | 18.45K | 18.11K | 12.54K | 10.92K | 9.96K | 9.39K |
| Additional Paid-In Capital | 230.11M | 225.84M | 201.10M | 170.62M | 145.55M | 123.90M |
| Retained Earnings | -233.71M | -216.61M | -182.11M | -144.50M | -101.56M | -60.70M |
| Shareholders' Equity | -3.58M | 9.25M | 19.00M | 26.13M | 44.00M | 63.21M |
| Total Liabilities & Equity | 8.81M | 30.49M | 45.36M | 59.39M | 77.01M | 67.20M |
| Total Debt | 4.36M | 16.93M | 21.83M | 23.85M | 23.47M | 490.35K |
| Net Cash (Debt) | 1.23M | 9.79M | 19.86M | 32.71M | 50.35M | 64.75M |
| Net Cash Per Share | 0.02 | 0.21 | 0.54 | 1.06 | 1.76 | 2.53 |
| Filing Date Shares Outstanding | 55.97M | 55.82M | 45.40M | 36.68M | 30.72M | 28.45M |
| Total Common Shares Outstanding | 55.92M | 54.88M | 37.99M | 33.09M | 30.17M | 28.45M |
| Working Capital | -5.33M | 18.77M | 27.97M | 45.43M | 66.66M | 63.08M |
| Book Value Per Share | -0.06 | 0.17 | 0.50 | 0.79 | 1.46 | 2.22 |
| Tangible Book Value | -3.58M | 9.25M | 19.00M | 26.13M | 44.00M | 63.21M |
| Tangible Book Value Per Share | -0.06 | 0.17 | 0.50 | 0.79 | 1.46 | 2.22 |
| Machinery | 295.91K | 295.91K | 266.91K | 115.42K | 115.42K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -33.67M | -34.50M | -37.61M | -42.94M | -40.85M | -16.92M |
| Depreciation & Amortization | 60.52K | 60.52K | 59.79K | 57.33K | 49.08K | 5.36K |
| Other Amortization | 881.62K | 1.55M | 1.16M | 652.01K | 183.91K | |
| Stock-Based Compensation | 4.69M | 4.11M | 6.85M | 7.61M | 5.20M | 4.07M |
| Other Operating Activities | 3.86M | 1.41M | 267.00K | 1.18M | 5.24M | 276.78K |
| Change in Accounts Payable | 1.90M | 1.89M | -5.30M | 5.76M | -90.12K | -105.82K |
| Change in Other Net Operating Assets | 5.50M | -2.27M | -453.77K | -5.96M | 4.57M | 181.64K |
| Operating Cash Flow | -16.78M | -27.75M | -35.03M | -33.64M | -25.71M | -12.49M |
| Capital Expenditures | -29.00K | |||||
| Investing Cash Flow | -29.00K | |||||
| Long-Term Debt Issued | 18.16M | 25.00M | ||||
| Long-Term Debt Repaid | -25.73M | -3.18M | -59.30K | |||
| Net Debt Issued (Repaid) | -19.90M | -7.56M | -3.18M | -59.30K | 25.00M | |
| Issuance of Common Stock | 6.15M | 13.98M | 23.37M | 16.44M | 10.01M | 48.89M |
| Repurchase of Common Stock | -270.96K | |||||
| Other Financing Activities | 4.25M | 6.35M | -449.33K | |||
| Financing Cash Flow | -9.49M | 12.77M | 20.19M | 16.38M | 34.29M | 48.89M |
| Net Cash Flow | -26.28M | -14.98M | -14.87M | -17.26M | 8.58M | 36.40M |
| Free Cash Flow | -16.78M | -27.75M | -35.06M | -33.64M | -25.71M | -12.49M |
| Free Cash Flow Per Share | -0.32 | -0.60 | -0.96 | -1.09 | -0.90 | -0.49 |
| Levered Free Cash Flow | -13.76M | -15.72M | -23.34M | -21.17M | -16.47M | -9.04M |
| Unlevered Free Cash Flow | -10.48M | -13.93M | -21.57M | -19.19M | -15.83M | -9.04M |
| Cash Interest Paid | 2.85M | 2.92M | 3.56M | 3.54M | 852.22K | |
| Change in Working Capital | 7.40M | -382.97K | -5.75M | -199.28K | 4.47M | 75.82K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 104.36M | 42.12M | 60.98M | 154.61M | 376.31M | 230.35M |
| Enterprise Value | 103.13M | 33.89M | 35.90M | 123.96M | 328.03M | 161.13M |
| Last Close Price | 1.44 | 0.77 | 1.63 | 4.97 | 13.20 | 8.10 |
| PB Ratio | 4.55 | 3.21 | 5.92 | 8.55 | 3.64 | |
| P/TBV Ratio | 4.55 | 3.21 | 5.92 | 8.55 | 3.64 | |
| Debt / Equity Ratio | -1.22 | 1.83 | 1.15 | 0.91 | 0.53 | 0.01 |
| Net Debt / Equity Ratio | 0.34 | -1.06 | -1.04 | -1.25 | -1.14 | -1.02 |
| Net Debt / EBITDA Ratio | 0.04 | 0.31 | 0.55 | 0.76 | 1.21 | 3.02 |
| Net Debt / FCF Ratio | 0.07 | 0.35 | 0.57 | 0.97 | 1.96 | 5.19 |
| Quick Ratio | 0.45 | 2.82 | 2.44 | 4.15 | 7.52 | 17.37 |
| Current Ratio | 0.57 | 2.98 | 2.64 | 4.33 | 7.79 | 17.80 |
| Return on Equity (ROE) | -543.97% | -244.16% | -166.65% | -122.46% | -76.21% | -37.45% |
| Return on Assets (ROA) | -70.59% | -51.98% | -43.34% | -39.45% | -36.12% | -27.32% |
| Return on Capital Employed (ROCE) | 779.60% | -150.10% | -128.50% | -94.10% | -62.00% | -33.80% |
| Earnings Yield | -44.45% | -81.89% | -61.68% | -27.77% | -10.86% | -7.34% |
| FCF Yield | -16.08% | -65.88% | -57.50% | -21.76% | -6.83% | -5.42% |
| Buyback Yield / Dilution | -30.89% | -27.25% | -17.77% | -8.23% | -11.73% | -52.86% |